{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "579.80",
    "chg": -5.85,
    "chgp": "-1.0%",
    "dir": -1,
    "prev_price": "585.65",
    "mcapval": "13,968.81 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "India SENSEX",
    "isin": "INE065X01017",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "3.5 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "10039241",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/indegene-10039241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "06-Oct-2026",
      "details": "Press Release",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "30-Sep-2026",
      "details": "Intimation of Indegene Limited Q2 FY27 Earnings Call",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration Of The Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2026 Along With The Limited Review Report Of The Auditors Thereon.",
      "datetime": "30-Sep-2026",
      "details": "Indegene Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2026 along with the Limited Review Report of the Auditors thereon",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "29 Oct 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>112%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News